Story perspectives
KRAS Powers Aggressive Pancreatic Cancer, 5-Year Survival 13%
5/24/2026
1 of 1
Story summary
- KRAS drives the aggressive growth and rapid spread of pancreatic tumors.
- KRAS consistently acts as a key driver in nearly every case of pancreatic cancer.
- Pancreatic cancer currently leaves only 13 percent of patients overall alive after five years.
- Scientists initially discovered the mutated molecular protein KRAS in the early 1980s.
